OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Libido as a motivator for starting and restarting non-prescribed anabolic androgenic steroid use among men: a mixed-methods study
Orlanda Harvey, Margarete Parrish, Edwin van Teijlingen, et al.
Drugs Education Prevention and Policy (2021) Vol. 29, Iss. 3, pp. 276-288
Open Access | Times Cited: 17
Orlanda Harvey, Margarete Parrish, Edwin van Teijlingen, et al.
Drugs Education Prevention and Policy (2021) Vol. 29, Iss. 3, pp. 276-288
Open Access | Times Cited: 17
Showing 17 citing articles:
The Liver King Lie: Misrepresentation, justification, and public health implications
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
Nick Gibbs, Timothy Piatkowski
International Journal of Drug Policy (2023) Vol. 114, pp. 103979-103979
Open Access | Times Cited: 23
“I would never go to the doctor and speak about steroids”: Anabolic androgenic steroids, stigma and harm
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
Luke Cox, Timothy Piatkowski, Jim McVeigh
Drugs Education Prevention and Policy (2024), pp. 1-13
Open Access | Times Cited: 14
#Sponseredathlete: the marketing of image and performance enhancing drugs on Facebook and Instagram
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Nick Gibbs
Trends in Organized Crime (2023)
Open Access | Times Cited: 18
Big business: The private sector market for image and performance enhancing drug harm reduction in the UK
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Luke A. Turnock, Nick Gibbs, Luke Cox, et al.
International Journal of Drug Policy (2023) Vol. 122, pp. 104254-104254
Open Access | Times Cited: 18
Androgen abuse: Risks and adverse effects in men
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
Bonnie Grant, Elizabeth Hyams, Rhianna Davies, et al.
Annals of the New York Academy of Sciences (2024) Vol. 1538, Iss. 1, pp. 56-70
Open Access | Times Cited: 7
Getting big but not hard: A retrospective case-study of a male powerlifter's experience of steroid-induced erectile dysfunction
Justin Kotzé, Andrew Richardson, Georgios A. Antonopoulos
International Journal of Drug Policy (2023) Vol. 121, pp. 104195-104195
Open Access | Times Cited: 11
Justin Kotzé, Andrew Richardson, Georgios A. Antonopoulos
International Journal of Drug Policy (2023) Vol. 121, pp. 104195-104195
Open Access | Times Cited: 11
Performance and Image Enhancing Drug Use Among Australian Women: The Role of Interpersonal Relationships in Facilitating Use
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 142-159
Open Access | Times Cited: 4
Timothy Piatkowski, Bianca Whiteside, Jonathan Robertson, et al.
Contemporary Drug Problems (2024) Vol. 51, Iss. 2, pp. 142-159
Open Access | Times Cited: 4
Exploring the Impacts of Rurality on Service Access and Harm Among Image and Performance Enhancing Drug (IPED) Users in a Remote English Region
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
Luke A. Turnock, Kyle Mulrooney
Contemporary Drug Problems (2023) Vol. 50, Iss. 2, pp. 232-253
Open Access | Times Cited: 10
Semaglutide, Testosterone and Sildenafil advertising on social media: The Normalisation of lifestyle enhancement drugs
Mikey Hirst, Luke A. Turnock
Performance Enhancement & Health (2024), pp. 100303-100303
Open Access | Times Cited: 3
Mikey Hirst, Luke A. Turnock
Performance Enhancement & Health (2024), pp. 100303-100303
Open Access | Times Cited: 3
Use of Anabolic-Androgenic Steroids and Male Fertility: A Systematic Review and Meta-analysis
Prashant Motiram Mulawkar, Pankaj N. Maheshwari, Vineet Gauhar, et al.
Journal of Human Reproductive Sciences (2023) Vol. 16, Iss. 4, pp. 268-285
Open Access | Times Cited: 7
Prashant Motiram Mulawkar, Pankaj N. Maheshwari, Vineet Gauhar, et al.
Journal of Human Reproductive Sciences (2023) Vol. 16, Iss. 4, pp. 268-285
Open Access | Times Cited: 7
Novel wellbeing and repair peptide use in the UK: Netnographic findings
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Luke A. Turnock, Evelyn Hearne
Performance Enhancement & Health (2024), pp. 100293-100293
Open Access | Times Cited: 2
Generating evidence on the use of Image and performance enhancing drugs in the UK: results from a scoping review and expert consultation by the Anabolic Steroid UK network
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
Jim McVeigh, Evelyn Hearne, Ian D. Boardley, et al.
Harm Reduction Journal (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 16
‘Sustaining masculinity’: a scoping review of anabolic androgenic steroid use by older males
Evelyn Hearne, Amanda Atkinson, Ian D. Boardley, et al.
Drugs Education Prevention and Policy (2022) Vol. 31, Iss. 1, pp. 27-53
Open Access | Times Cited: 10
Evelyn Hearne, Amanda Atkinson, Ian D. Boardley, et al.
Drugs Education Prevention and Policy (2022) Vol. 31, Iss. 1, pp. 27-53
Open Access | Times Cited: 10
Exploring user narratives of self-medicated black market IPED use for therapeutic & wellbeing purposes
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Luke A. Turnock
Performance Enhancement & Health (2021) Vol. 10, Iss. 2, pp. 100207-100207
Closed Access | Times Cited: 13
Systems mapping to understand complexity in the association between image and performance enhancing drugs (IPEDs) and harm
Geoff Bates, Robert Ralphs, Vincent Walker Bond, et al.
International Journal of Drug Policy (2022) Vol. 107, pp. 103801-103801
Open Access | Times Cited: 6
Geoff Bates, Robert Ralphs, Vincent Walker Bond, et al.
International Journal of Drug Policy (2022) Vol. 107, pp. 103801-103801
Open Access | Times Cited: 6
A review of recent evidence on androgen abuse from interviews with users
Bonnie Grant, Suks Minhas, Channa N. Jayasena
Current Opinion in Endocrinology Diabetes and Obesity (2023) Vol. 30, Iss. 6, pp. 285-290
Open Access | Times Cited: 3
Bonnie Grant, Suks Minhas, Channa N. Jayasena
Current Opinion in Endocrinology Diabetes and Obesity (2023) Vol. 30, Iss. 6, pp. 285-290
Open Access | Times Cited: 3
Struggling to reply to reviewers: Some advice for novice researchers
Orlanda Harvey, Alison M. Taylor, Pramod Regmi, et al.
Health Prospect (2022) Vol. 21, Iss. 2, pp. 19-22
Open Access | Times Cited: 1
Orlanda Harvey, Alison M. Taylor, Pramod Regmi, et al.
Health Prospect (2022) Vol. 21, Iss. 2, pp. 19-22
Open Access | Times Cited: 1
